This title appears in the Scientific Report :
2014
Please use the identifier:
http://dx.doi.org/10.4236/wjns.2014.44040 in citations.
Please use the identifier: http://hdl.handle.net/2128/7899 in citations.
Neuropeptide Receptors in Pain Circuitries: Useful Targets for CNS Imaging with Non-Peptide Ligands Suitable for PET?
Neuropeptide Receptors in Pain Circuitries: Useful Targets for CNS Imaging with Non-Peptide Ligands Suitable for PET?
Neuropeptide receptors of the brain and spinal cord are parts of the pain circuits targeted byanalgesic drugs. Some of these receptors have been found in the central nervous system as well asin intracranial vascular structures and achieved revival of attention because of their role in acuteand chron...
Saved in:
Personal Name(s): | Pissarek, Margit (Corresponding Author) |
---|---|
Contributing Institute: |
Nuklearchemie; INM-5 |
Published in: | World Journal of Neuroscience, 04 (2014) 04, S. 353 - 383 |
Imprint: |
Irvine, CA
Scientific Research Publ.
2014
|
DOI: |
10.4236/wjns.2014.44040 |
Document Type: |
Journal Article |
Research Program: |
Neuroimaging Pathophysiological Mechanisms of Neurological and Psychiatric Diseases |
Link: |
OpenAccess |
Publikationsportal JuSER |
Please use the identifier: http://hdl.handle.net/2128/7899 in citations.
LEADER | 04406nam a2200565 a 4500 | ||
---|---|---|---|
001 | 155302 | ||
005 | 20220930130031.0 | ||
024 | 7 | |a 10.4236/wjns.2014.44040 |2 doi | |
024 | 7 | |a 2162-2000 |2 ISSN | |
024 | 7 | |a 2162-2019 |2 ISSN | |
024 | 7 | |a 2128/7899 |2 Handle | |
024 | 7 | |a altmetric:2905248 |2 altmetric | |
037 | |a FZJ-2014-04475 | ||
082 | |a 610 | ||
100 | 1 | |a Pissarek, Margit |0 P:(DE-Juel1)131839 |b 0 |e Corresponding Author |u fzj | |
245 | |a Neuropeptide Receptors in Pain Circuitries: Useful Targets for CNS Imaging with Non-Peptide Ligands Suitable for PET? | ||
260 | |a Irvine, CA |c 2014 |b Scientific Research Publ. | ||
520 | |a Neuropeptide receptors of the brain and spinal cord are parts of the pain circuits targeted byanalgesic drugs. Some of these receptors have been found in the central nervous system as well asin intracranial vascular structures and achieved revival of attention because of their role in acuteand chronic pain syndromes. A number of them are of high clinical relevance for e.g. migraine.Others participate in symptoms of rare diseases like amyotrophic lateral sclerosis. Here we willfocus on five of the neuropeptide receptors and their non-peptide ligands potentially or alreadysuccessfully used as PET probes. Opioid receptors and neurotensin receptors are known tomediate analgesic actions. Bradykinin and calcitonin gene-related peptide (CGRP) receptors areknown to be involved in the regulation of vascular tone and inflammatory responses, and neurokininreceptors play a role in the occurrence of pain perception in a rather indirect manner. Mostexperiences as PET tracers have been gathered with opioid receptor ligands and neurokininreceptor ligands. The most innovative fields revealed by the studies summarized in this report arethe ligands of κ opioid receptors and CGRP receptors for which a first PET tracer was presentedrecently. | ||
588 | |a Dataset connected to CrossRef, juser.fz-juelich.de | ||
773 | |a 10.4236/wjns.2014.44040 |g Vol. 04, no. 04, p. 353 - 383 |0 PERI:(DE-600)2681393-2 |n 04 |p 353 - 383 |t World Journal of Neuroscience |v 04 |y 2014 |x 2162-2019 | ||
856 | 4 | |u http://juser.fz-juelich.de/record/155302/files/FZJ-2014-04475.pdf |y OpenAccess | |
856 | 4 | |u http://juser.fz-juelich.de/record/155302/files/FZJ-2014-04475.jpg?subformat=icon-144 |x icon-144 |y OpenAccess | |
856 | 4 | |u http://juser.fz-juelich.de/record/155302/files/FZJ-2014-04475.jpg?subformat=icon-180 |x icon-180 |y OpenAccess | |
856 | 4 | |u http://juser.fz-juelich.de/record/155302/files/FZJ-2014-04475.jpg?subformat=icon-640 |x icon-640 |y OpenAccess | |
909 | C | O | |o oai:juser.fz-juelich.de:155302 |p openaire |p open_access |p OpenAPC |p driver |p VDB |p openCost |p dnbdelivery |
910 | 1 | |a Forschungszentrum Jülich GmbH |0 I:(DE-588b)5008462-8 |k FZJ |b 0 |6 P:(DE-Juel1)131839 | |
913 | 2 | |a DE-HGF |b Key Technologies |l Decoding the Human Brain |1 G:(DE-HGF)POF3-570 |0 G:(DE-HGF)POF3-573 |2 G:(DE-HGF)POF3-500 |v Neuroimaging |x 0 | |
913 | 1 | |a DE-HGF |b Gesundheit |l Funktion und Dysfunktion des Nervensystems |1 G:(DE-HGF)POF2-330 |0 G:(DE-HGF)POF2-333 |2 G:(DE-HGF)POF2-300 |v Pathophysiological Mechanisms of Neurological and Psychiatric Diseases |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF2 | |
913 | 1 | |a DE-HGF |0 G:(DE-HGF)POF2-89573 |v Neuroimaging |x 1 |4 G:(DE-HGF)POF |1 G:(DE-HGF)POF3-890 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-800 |b Programmungebundene Forschung |l ohne Programm | |
914 | 1 | |y 2014 | |
915 | |a Peer Review unknown |0 StatID:(DE-HGF)0040 |2 StatID | ||
915 | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ | ||
915 | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID | ||
980 | 1 | |a FullTexts | |
980 | |a journal | ||
980 | |a VDB | ||
980 | |a UNRESTRICTED | ||
980 | |a FullTexts | ||
980 | |a I:(DE-Juel1)INM-5-20090406 | ||
980 | |a APC | ||
536 | |a Neuroimaging |0 G:(DE-HGF)POF2-89573 |c POF2-89573 |x 1 |f POF II T | ||
536 | |a Pathophysiological Mechanisms of Neurological and Psychiatric Diseases |0 G:(DE-HGF)POF2-333 |c POF2-333 |f POF II |x 0 | ||
336 | |a ARTICLE |2 BibTeX | ||
336 | |a Nanopartikel unedler Metalle (Mg0, Al0, Gd0, Sm0) |0 0 |2 EndNote | ||
336 | |a Output Types/Journal article |2 DataCite | ||
336 | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 155302 |2 PUB:(DE-HGF) | ||
336 | |a article |2 DRIVER | ||
336 | |a JOURNAL_ARTICLE |2 ORCID | ||
920 | |k Nuklearchemie; INM-5 |0 I:(DE-Juel1)INM-5-20090406 |l Nuklearchemie |x 0 | ||
990 | |a Pissarek, Margit |0 P:(DE-Juel1)131839 |b 0 |e Corresponding Author |u fzj |